General Information of Drug (ID: DMKX174)

Drug Name
FOR46
Indication
Disease Entry ICD 11 Status REF
Multiple myeloma 2A83 Phase 1 [1]
Drug Type
Antibody drug conjugate
Cross-matching ID
TTD ID
D48ZBO

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Membrane cofactor protein (CD46) TTMS7DF MCP_HUMAN Not Available [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT03650491) A Study of FOR46 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM). U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of Fortis Therapeutics.